The role of TGF-β2 in cartilage development and diseases

Transforming growth factor-beta2 (TGF-beta 2) is recognized as a versatile cytokine that plays a vital role in regulation of joint development, homeostasis, and diseases, but its role as a biological mechanism is understood far less than that of its counterpart, TGF-beta 1. Cartilage as a load-resisting structure in vertebrates however displays a fragile performance when any tissue disturbance occurs, due to its lack of blood vessels, nerves, and lymphatics. Recent reports have indicated that TGF-beta 2 is involved in the physiological processes of chondrocytes such as proliferation, differentiation, migration, and apoptosis, and the pathological progress of cartilage such as osteoarthritis (OA) and rheumatoid arthritis (RA). TGF-beta 2 also shows its potent capacity in the repair of cartilage defects by recruiting autologous mesenchymal stem cells and promoting secretion of other growth factor clusters. In addition, some pioneering studies have already considered it as a potential target in the treatment of OA and RA. This article aims to summarize the current progress of TGF-beta 2 in cartilage development and diseases, which might provide new cues for remodelling of cartilage defect and intervention of cartilage diseases.

Automated summary

TGF-beta 2 plays a crucial role in cartilage development and diseases by participating in both physiological and pathological processes of chondrocytes, and demonstrating potential in repairing cartilage defects. It is considered as a potential target in the treatment of osteoarthritis and rheumatoid arthritis, showing promising prospects for intervention in cartilage diseases.